| İleri evre kanser tedavisinde interlökin-2 immünoterapisi | Dilara SAHİN,Onur BOYMAN | 61–68 |
| Interleukin-2 Immunotherapy for Advanced Cancer | Dilara SAHİN, Onur BOYMAN | 61–68 |
| DMBA ile Oluşturulmuş Meme Kanserli Sıçanlarda CD4+CD25+ Regülatuvar T Hücre IL-10 ve TGF-beta içeriklerine Propolis Ekstresinin Düzenleyici Etkisi | Zauhani KUSNUL,Pudji RAHAYU,Muhaimin RİFA’İ,Edi WİDJAJANTO | 69–76 |
| Immunomodulatory Effect of Propolis Extract on Population of IL-10 and TGF-β Expression in CD4+CD25+ Regulatory T Cells in DMBA-induced Breast Cancer in Female Sprague-Dawley Rats | Edi WİDJAJANTO, Muhaimin RİFA’İ, Zauhani KUSNUL, Pudji RAHAYU | 69–76 |
| Retrospective Evaluation of Results of Autoantibodies Detected by IFA in a Training and Research Hospital | Gülseren SAMANCI AKTAR,Zeynep AYAYDIN,Arzu RAHMANLI ONUR,Demet GÜR VURAL,Hakan TEMİZ | 77–81 |
| İnsan Zona Pellusida 3’e Karşı Oluşturulan Monoklonal Antikorun Kemik Şekillendirici Protein 15 ve Fare overinde Preantral ve Antral Folikül Sayısına Olan Etkisi | Reny RETNANİNGSİH,Endang WAHYUNİ,Kusnarman KEMAN | 82–88 |
| Effect of Monoclonal Antibody to Human Zone Pellucida 3 on Bone Morphogenetic Protein 15 Expression and Number of Preantral and Antral Follicles in Ovary of Mice | Reny RETNANİNGSİH, Kusnarman KEMAN, Endang WAHYUNİ | 82–88 |
| 1,25(OH)2 D3, Sistemik Lupus Eritematozus Hastalarında Nötrofil Hücre Dışı Tuzakları ile Endotel Apoptozunu Baskılar | Kusworini HANDONO,Benny Arie PRADANA,Radhitio Adi NUGROHO,Dian HASANAH,Handono KALIM,Agustina Tri ENDHARTI | 89–95 |
| 1,25(OH)2 D3 Inhibits Endothelial Apoptosis by Neutrophil Extracellular Traps Externalization in Systemic Lupus Erythematosus Patients | Kusworini HANDONO, Agustina Tri ENDHARTI, Handono KALİM, Benny Arie PRADANA, Radhitio Adi NUGROHO, Dian HASANAH | 89–95 |
| İleri Evre Nazofarinks Karsinomunda Latent Membran Protein-1 ile CD80, CD86, MHC-I ve CD8 antijenlerinin ilişkisi | Made SETİAMİKA,Edi WİJAJANTO,Aris WİDODO,Pudji RAHAYU | 96–102 |
| The Association Between Latent Membrane Protein-1 and CD80, CD86, MHC-I and CD8 in Advanced Stage Nasopharyngeal Carcinoma |